Charles River Laboratories | CRL - Cost Of Sales

Stock Price
154.24
Daily Change
1.81 1.19%
Monthly
-15.76%
Yearly
14.27%
Q2 Forecast
147.82

Charles River Laboratories reported $716.51M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Align Technology USD 303.5M 60.47M Mar/2026
Bio-Rad Laboratories USD 348M 38.4M Dec/2025
Bruker USD 443.6M 84.4M Mar/2026
Cardinal Health USD 58.54B 4.82B Mar/2026
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Cigna USD 62.41B 4.1B Mar/2026
Concord Medical Services Hldg CNY 204.9M 117.04M Jun/2025
CVS Health USD 84.8B 7.32B Mar/2026
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 453M 65M Mar/2026
Elevance Health USD 38.07B 75M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
Illumina USD 370M 30M Mar/2026
Incyte USD 104.5M 16.68M Mar/2026
Intrexon USD 1.01M 344K Jun/2024
IQVIA Holdings USD 3.08B 161M Mar/2026
Laboratory Of America USD 2.6B 4.2M Mar/2026
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Lonza CHF 2.28B 189M Jun/2025
McKesson USD 92.25B 10.22B Mar/2026
Merck EUR 2.07B 219M Mar/2026
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Pfizer USD 4.59B 1.7B Mar/2026
Quest Diagnostics USD 1.99B 57M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
United Therapeutics USD 133.4M 341.3M Mar/2026
UnitedHealth USD 94.72B 2.2B Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Waters USD 725M 350.06M Mar/2026
West Pharmaceutical Services USD 548.5M 47.4M Mar/2026